PLADOX

This brand name is authorized in Nigeria.

Active ingredients

The drug PLADOX contains one active pharmaceutical ingredient (API):

1	Clopidogrel UNII 08I79HTP27 - CLOPIDOGREL BISULFATE
	Clopidogrel is a prodrug, one of whose metabolites is an inhibitor of platelet aggregation. Clopidogrel must be metabolised by CYP450 enzymes to produce the active metabolite that inhibits platelet aggregation.
	Read more about Clopidogrel

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-5967	Tablet	Pladox 75 mg Tablets (duplicate, different product) TAB 75 mg 3 x 10's (in Alu-Alu blisters)	Tablet Pink colored, round, film coated tablets with "C4" debossed on one side and plain on the other side PLADOX 75MG TABLETS CLOPIDOGREL BISULFATE Clopidogrel Bisulfate -.75mg Lactose, Anhydrous - 94.425mg Microcrystalline Cellulose- 26.200mg L-Hydroxypropyl celluloseLH-21 – 22.500mg Polyethylene glycol 6000- 3.000mg Hydrogenated castor oil – 6.000mg Opadry 03B54564 – 6.000mg Purified Water $ - -Qs A4-5967 Drugs Imported Products 3X10 POM 1 06/04/2022 FIDSON HEALTHCARE PLC, IKORODU ROAD, OBANIKORO LAGOS LAGOS 8023067964 nmakaokolo@yahoo.com V.S. International Pvt. Ltd, Plot no 17 & 18 Golden Industrial Estate, Somnath Road, Dabhel, Daman 396 210 India , India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AC04	Clopidogrel	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-5967